Use caution Medical device recall · FDA · Published January 15, 2025

Getinge Vaporizer Sevoflurane Recall: Hydrogen Fluoride Risk During Anesthesia

Getinge recalls specific vaporizers used in anesthesia due to potential hydrogen fluoride release from sevoflurane. This could cause respiratory irritation or severe health issues. Affected models include Flow-i C20, C30, C40.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-1074-2025Medical device Getinge ›

Use caution until it’s fixed

Sevoflurane used with the vaporizer may degrade to hydrogen fluoride, which could present a risk to patients or health care providers through inhalation and/or skin exposure. Potential harms include irritation of respiratory tract, which in worst case may lead to lung edema and/or severe hypocalcemia, blistering, superficial ulceration, and/or hypomagnesemia.

Take action

Contact the company

Recalling firmGetinge Usa Sales Inc1 Geoffrey Way · Wayne, NJ 07470-2035

✎ GovInfoNow plain-language explainer

Getinge is recalling vaporizers used with sevoflurane anesthesia because they may release hydrogen fluoride, which can cause serious health problems like lung damage or severe electrolyte imbalances. This is a safety risk for healthcare providers and patients during anesthesia procedures. Read more at govinfonow.com/recall/53085-getinge-vaporizer-sevoflurane-recall-hydrogen-fluoride-risk-during-anesthesia.

Source Summary by GovInfoNow · govinfonow.com/recall/53085-getinge-vaporizer-sevoflurane-recall-hydrogen-fluoride-risk-during-anesthesia · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1074-2025

Cite this page

“Getinge Vaporizer Sevoflurane Recall: Hydrogen Fluoride Risk During Anesthesia.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53085-getinge-vaporizer-sevoflurane-recall-hydrogen-fluoride-risk-during-anesthesia. Based on FDA recall #Z-1074-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1074-2025%22&limit=1).

The FDA announced on Jan. 15, 2025, that Getinge Usa Sales Inc is recalling the Vaporizer Sevoflurane, Quik-Fil (Model No. 6682285) due to a Class I hazard. The device may degrade sevoflurane into hydrogen fluoride, posing inhalation and skin exposure risks.

How to tell if you have it

Brand: Getinge
Product: Vaporizer Sevoflurane, Quik-Fil
Model Number: 6682285
UDI-DI: 07325710001141
Serial Numbers: 3761, 7635, 7633, 7630, 7632, 7631
Component of: Flow-i C20, Flow-i C30, Flow-i C40, Flow-c, Flow-e
Quantity: 6 units
Distribution: Domestic to Kentucky and Connecticut

The hazard

According to the FDA, sevoflurane used with the vaporizer may degrade to hydrogen fluoride, which could present a risk to patients or health care providers through inhalation and/or skin exposure. Potential harms include irritation of the respiratory tract, which in worst case may lead to lung edema and/or severe hypocalcemia, blistering, superficial ulceration, and/or hypomagnesemia.

Context

GovInfoNow's records show Getinge Usa Sales Inc has 16 other recalls on record since Dec. 9, 2021. Other recent recalls of similar products include Mindray Sevoflurane V90 Vaporizer Recall (Oct. 20, 2025), Mindray Isoflurane V90 Vaporizer Recall (Oct. 20, 2025), and Draeger Vapor 3000 Anesthetic Vaporizer Recall (Nov. 24, 2025).

How to tell if you have this one

Check for model number 6682285 on the vaporizer. The device is part of Flow-i C20, C30, C40, Flow-c, or Flow-e anesthesia systems. Serial numbers 3761, 7635, 7633, 7630, 7632, 7631 are affected.

Brand
Getinge
Category
Medical device

Based on the official FDA remedy

What to do — step by step

Check Vaporizer Model
Verify the model number is 6682285 on the vaporizer itself.
Contact Getinge
Reach out to Getinge for guidance on next steps if the vaporizer is affected.

Where it went and when

Where it was distributed

Distributed in Connecticut and Kentucky.

FDA distribution: “Domestic distribution to Kentucky and Connecticut.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Connecticut, Kentucky.

Recall timeline

FDA published this recall 35 days after the firm started it.

Jan 15, 2025Firm started the recall
Feb 7, 2025FDA classified it Class I
Feb 19, 2025Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

More Getinge recalls

Link to this recall

<a href="https://govinfonow.com/recall/53085-getinge-vaporizer-sevoflurane-recall-hydrogen-fluoride-risk-during-anesthesia">Getinge Vaporizer Sevoflurane Recall: Hydrogen Fluoride Risk During Anesthesia (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #Z-1074-2025 (January 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1074-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.